Most account plans fail because the process behind them is vague. A rep gets a template, fills in the obvious fields, and saves it to a folder no one opens.
A real account planning process is a sequence of structured inputs that produce a decision. Which stakeholders do we need to influence. Where is the whitespace. What is the growth bet. How will we execute.
This guide walks through the seven steps of an account planning process that works. We will use a running example, a fictional enterprise account called Acme Pharma, so each step stays concrete.
For the broader category view, see our pillar on Salesforce account planning.
Meet Acme Pharma
Acme Pharma is a $12B specialty pharmaceutical manufacturer. They buy our platform in their clinical operations group. We have $400K in ARR across two business units. The account has been a customer for three years. Renewal is in six months.
That is what we know. Now we plan.
Step 1: Account Research
The first step is fact finding. Do not skip it because you already know the account. Three-year customers are often the ones reps know least well at the executive level.
Pull the public record. Annual report. Earnings calls. 10-K. Press releases from the last twelve months. Analyst coverage. Job postings.
Pull the internal record. Support tickets. Product usage. NPS scores. Previous QBRs. Every closed-won and closed-lost opportunity.
Write down the five things that matter most. For Acme Pharma, it might be: they acquired a rare disease portfolio last quarter, they announced a digital transformation initiative, their new CIO came from a competitor customer, they missed on specialty revenue last quarter, and they just opened a commercial manufacturing site in Ireland.
These are the anchors for every other step.
Step 2: Stakeholder Mapping
Now map the people. Who signs. Who influences. Who blocks. Who champions.
Start with the org chart. Pull it from LinkedIn Sales Navigator. Overlay your existing relationships. Mark each contact as champion, supporter, neutral, skeptic, or blocker.
For Acme Pharma, we have strong relationships in clinical operations. We have one contact in commercial manufacturing. We have zero coverage in the new rare disease business unit. The new CIO is unmapped.
That is the gap. Coverage in the buying unit we already sell into, whitespace in the business units where the growth is.
Stakeholder mapping is not a LinkedIn screenshot with photos on it. It is a decision tool. For every stakeholder, you should know their role in the next deal, their sentiment, and your plan to move them. Go deeper in our guide to stakeholder analysis.
Step 3: Whitespace Analysis
Whitespace is where the growth lives. It is the intersection of what you sell and what the customer has not bought yet.
Build a grid. Rows are products. Columns are business units, sites, or geographies. Each cell is either sold, in pilot, evaluated and lost, or never discussed.
For Acme Pharma, the grid shows two products sold into clinical operations, one product in pilot in commercial manufacturing, and nothing in rare disease or at the new Ireland site.
That grid is now your target list. Rare disease is net new. Ireland is expansion of an existing product into a new site. Commercial manufacturing pilot is a conversion opportunity.
Pick the top three whitespace plays. Not ten. Three. Our full guide to whitespace analysis covers the grid in more detail.
Step 4: Growth Plan
Now turn whitespace into a plan. For each of your top three plays, write down four things.
The target. Which business unit, which product, what size.
The stakeholders. Who do you need to influence to win it.
The trigger. What event or pain makes this the right time.
The path. What are the next three actions.
For Acme Pharma, play one might be: expand our existing clinical product into commercial manufacturing at the Ireland site. Stakeholder is the VP of Manufacturing Operations and the site director. Trigger is the Ireland site coming online next quarter. Path is a technical workshop in month one, a pilot scope in month two, a signed order in month three.
Play two: land in rare disease. Stakeholder is the new business unit head. Trigger is the acquisition and the integration work. Path is an executive introduction via our champion in clinical operations.
Play three: convert the commercial manufacturing pilot to a paid deployment. Stakeholder is the current pilot sponsor and their director. Trigger is the pilot end date in 45 days. Path is a pilot review QBR with quantified results.
Each play has an owner, a number, and a date. If it does not, it is not a plan.
Step 5: Risk and Blockers
Every plan needs a risk section. Not because it is good hygiene. Because risks surface the work you have not done yet.
List the top five risks. For each, list the mitigation.
Acme Pharma risks might include: new CIO is unmapped and could reset strategy; our champion in clinical operations is rumored to be leaving; a competitor has been sighted in rare disease; the Ireland site validation timeline could slip; pricing pressure from procurement at renewal.
Mitigations. Get the new CIO meeting within 30 days through our executive sponsor. Build a backup relationship in clinical operations with our champion's number two. Run a competitive displacement play in rare disease. Propose a joint validation plan for Ireland. Start the renewal conversation now with a multi-year structure.
Risks you cannot mitigate are reasons to lower your forecast. Risks you can mitigate are workstreams.
Step 6: QBR Cadence
Plans without a review cadence rot. Build the cadence into the plan.
For a Tier 1 account like Acme Pharma, that means a monthly internal review, a quarterly business review with the customer, and an annual executive alignment.
The monthly internal review is a 30-minute check. Are we on track against the three plays. What moved. What is stuck. Who needs executive air cover.
The quarterly business review is with the customer. It reviews value delivered, open issues, and the forward roadmap. It also surfaces new whitespace and new stakeholders.
The annual executive alignment is a half-day session with the customer's executive sponsor and yours. It sets strategic direction for the next year and typically anchors a multi-year commercial conversation.
Put all three on the calendar now. If the QBR slips, the plan has slipped.
Step 7: Execution Review
The last step is the one most teams skip. Close the loop.
At the end of each quarter, go back to the plan. Did the three plays land. If yes, what did we learn. If no, what broke.
Track leading indicators, not just closed-won. Did we get the new CIO meeting. Did we map ten stakeholders in rare disease. Did we complete the Ireland technical workshop. These are the signals that the plan is working before the revenue shows up.
Update the plan. Retire plays that are done. Add new plays based on what you learned. Re-tier the account if its strategic value changed.
A plan you never revisit is a document. A plan you review every quarter is a management system.
How Long Should the Process Take
For a Tier 1 account, the full process takes a rep about six to eight hours spread across two weeks. Two hours of research. Two hours of stakeholder mapping and whitespace. Two to three hours of growth plan. One hour of risk and cadence. One hour of internal review.
That sounds like a lot. It is less than the rep will waste on a bad deal in an unplanned account in a single month.
For a Tier 2 account, cut it to two hours. For a Tier 3 account, run a play, not a plan.
Where Most Account Planning Processes Break
Three patterns show up repeatedly.
The template gets filled in once. The rep fills fields to satisfy the manager and never opens the plan again. The fix is a QBR cadence that forces the plan to be live.
The plan is disconnected from Salesforce. It lives in PowerPoint or a wiki. Opportunities, contacts, and activities update in Salesforce. The plan goes stale within a week. The fix is to build the plan on the Account record.
There is no whitespace analysis. Without it, the growth plan is a list of hopes. With it, the growth plan is a list of specific business units and products.
Fix those three and you have a real process. Ignore them and you have a ritual.
Bring it into Salesforce with CRUSH
The process in this post is platform-agnostic. The execution is not.
CRUSH runs the entire account planning process inside Salesforce. Research on the Account. Stakeholder mapping tied to Contacts. Whitespace mapped to Products. Growth plans tied to Opportunities. QBR cadence on the Activity timeline.
No separate tool. No separate login. No PowerPoint graveyards.
Book a demo and see how enterprise sales teams run this seven-step process without leaving their CRM.
